ASCO Lung Cancer
Conference Coverage
Lung Cancer Expert at ASCO: From Fatal to ‘Chronic Disease’
Tony Shu-Kam Mok, MD, discusses latest KRAS G12C findings and more.
Latest News
ASCO Releases Vaccination Guidelines for Adults With Cancer
Oncologists may be key in ensuring patients with cancer safely receive vaccinations and avert avoidable infections.
Conference Coverage
The shifting sands of lung cancer screening
Studies find encouraging trends of stage shifting and minority screening, but more work remains.
The Practicing Oncologist
My picks for best of ASCO 2022
First-line treatment for colorectal cancer, possible new standard of care for breast cancer, and more.
Diminutio
Patients with blood cancers underutilize palliative care
Today in “Diminutio,” Sarah D’Ambruoso, NP, highlights this and other key presentations on palliative care from the ASCO annual meeting.
Conference Coverage
Promising treatment option for incurable lung cancer described as ‘significant’
Investigators suggest this combo should be standard therapy for NSCLC going forward.
Conference Coverage
Oncologists flock to Chicago for ASCO, after 2 years online
The theme of the 2022 meeting is advancing equitable cancer care through innovation.
Conference Recap
Top Abstracts in Locally Advanced NSCLC From ASCO 2021
Dr Thomas Stinchcombe discusses key data on locally advanced NSCLC from ASCO 2021, including results of atezolizumab as adjuvant therapy and...
Conference Recap
Key Presentations on Advanced Non–Small Cell Lung Cancer From ASCO 2021
Dr Mark A. Socinski highlights studies on advanced NSCLC from ASCO 2021, including data on combination immunotherapy, immune adverse events, and...
Conference Coverage
HER3-targeted treatment demonstrates efficacy and safety in phase 1 lung cancer study
Conference Coverage
Surgical outcomes favor addition of nivolumab to neoadjuvant chemo in resectable lung cancers